Ramesh Kumar Ph.d.
Co-Founder, Chief Executive Officer, President & D
United States of America
Dr. Ramesh Kumar, Ph.D., co-founded Onconova Therapeutics, Inc. in 1998 and has been its Chief Executive Officer and President since 1998. Dr. Kumar served as Senior Director of Dr. Reddy's Laboratories Ltd. He has held positions in R&D or management at Princeton University, Bristol-Myers Squibb, DNX (later Nextran, a subsidiary of Baxter) and Kimeragen (Now Valigen), where he served as President of the Genomics and Transgenics Division. He serves as Director of Onconova Therapeutics, Inc. Dr. Kumar has published more than 50 publications spanning the areas of molecular oncology, transgenic animals, gene therapy and recombination. He is an inventor in 8 US Patents and many Patent applications. He co-edited the book "Molecular Basis of Human Cancer" in 1993. Dr. Kumar received his Ph.D. degree in Molecular Biology from the University of Illinois, Chicago and trained at the National Cancer Institute.